Tumefactive multiple sclerosis and fingolimod
Authors:
- 1 September 2014
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 344 (1-2) , 1-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Tumefactive MS lesions under fingolimodNeurology, 2013
- Tumefactive multiple sclerosis lesions under fingolimod treatmentNeurology, 2013
- Disease reactivation after fingolimod discontinuation in two multiple sclerosis patientsJournal of Neurology, 2012
- Tumefactive multiple sclerosis lesions under fingolimod treatmentNeurology, 2012
- Severe relapses under fingolimod treatment prescribed after natalizumabNeurology, 2012
- Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimodMultiple Sclerosis Journal, 2012
- Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawalMultiple Sclerosis Journal, 2012
- Severe multiple sclerosis relapse under fingolimod therapy: Incident or coincidence?Neurology, 2012
- HEMORRHAGING FOCAL ENCEPHALITIS UNDER FINGOLIMOD (FTY720) TREATMENT: A CASE REPORTNeurology, 2009
- POSTWITHDRAWAL REBOUND INCREASE IN T2 LESIONAL ACTIVITY IN NATALIZUMAB-TREATED MS PATIENTSNeurology, 2008